BIOSEIZER Trademark

Trademark Overview

On Tuesday, September 13, 2016, a trademark application was filed for BIOSEIZER with the United States Patent and Trademark Office. The USPTO has given the BIOSEIZER trademark a serial number of 87170078. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, September 16, 2024. This trademark is owned by TAIWAN LIPSOME CO., LTD.. The BIOSEIZER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development; biomedical research services; chemical, biochemical, biological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems; research and development of new products for medicinal and nutritional use for others
bioseizer

General Information

Serial Number87170078
Word MarkBIOSEIZER
Filing DateTuesday, September 13, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, September 16, 2024
Registration Number5494970
Registration DateTuesday, June 19, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements

Pseudo MarkBIO SEIZER
Goods and ServicesBiochemical research and development; biomedical research services; chemical, biochemical, biological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systems; research and development of new products for medicinal and nutritional use for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 16, 2016
Primary Code042
First Use Anywhere DateFriday, January 1, 2010
First Use In Commerce DateFriday, January 1, 2010

Trademark Owner History

Party NameTAIWAN LIPSOME CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei City 11503
TW
Party NameTAIWAN LIPSOME CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City 11503
TW
Party NameTAIWAN LIPSOME CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 11503
TW

Trademark Events

Event DateEvent Description
Tuesday, July 25, 2017ASSIGNED TO LIE
Friday, September 16, 2016NEW APPLICATION ENTERED
Friday, September 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 17, 2016NOTICE OF PSEUDO MARK E-MAILED
Monday, December 19, 2016ASSIGNED TO EXAMINER
Tuesday, December 20, 2016NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016NON-FINAL ACTION WRITTEN
Tuesday, June 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 15, 2017NON-FINAL ACTION WRITTEN
Monday, February 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 15, 2017NON-FINAL ACTION E-MAILED
Tuesday, August 15, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 16, 2018ASSIGNED TO LIE
Thursday, February 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, December 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 8, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, December 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 28, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, December 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 19, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 16, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 16, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, September 16, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

bioseizer research development services pharmaceutical medical field scientific drug clinical trials